echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The State Council requires that the list of key monitored drugs be implemented nationwide

    The State Council requires that the list of key monitored drugs be implemented nationwide

    • Last Update: 2019-11-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    National implementation of key monitoring drug catalog - the State Council requires that all provinces formulate and issue key monitoring drug catalog by the end of December ▍ recently, the national implementation of the list of key monitoring drugs, the State Council issued the notice of the leading group of the State Council on deepening the reform of the medical and health system on further promoting the experience of deepening the reform of the medical and health system in Fujian Province and Sanming City (hereinafter referred to as the notice) According to the notice of the State Council, all provinces shall formulate and issue the provincial key monitoring drug catalogue (chemical and biological products) by the end of December The notice requires strengthening the supervision and management of medical institutions, monitoring the hospital operation, the increase of the average cost of outpatient and inpatient times, the use of antibacterial drugs and auxiliary drugs, and increasing the notification and publicity of irrational drug use and other behaviors According to the notice, by the end of December 2019, each province shall formulate and issue the provincial key monitoring and rational drug use catalogue (chemical and biological products) and publish it By the end of December 2020, the key drug monitoring mechanism shall be fully established At the same time, all localities should strengthen the management and standardization of drug use catalogue in medical institutions, guide and promote all kinds of medical institutions at all levels to adjust and optimize drug use catalogue in time, and promote rational drug use ▍ the monitoring catalogue will continue to expand Li Congxuan, general manager of OTC Business Department of Kangmei pharmaceutical industry, told cypress blue that the latest drug management law can be said to be the most stringent in history, and many of the penalties are not subject to the upper limit From this point, we can see that the next step of drug supervision will certainly be strengthened, the scope of key monitoring drug catalogue will be expanded, and Chinese patent medicine will also be included The current situation of the Chinese patent medicine industry is that some Chinese patent medicines lack the barriers of access Whether it is the real estate area or not, the medicinal materials are planted A large number of Chinese patent medicine factories are built and put into production There is a phenomenon of disorderly competition and bad money expelling good money, Li Congxuan told cypress blue According to Li Congxuan, the scope of the key monitoring drug catalogue will be expanded and the management will be more and more strict, because the relevant departments must ensure the drug safety Another government official of a well-known domestic comprehensive pharmaceutical enterprise, who did not want to be named, said in an exchange with cypress blue that it is expected that the relevant departments of the state will definitely issue a second list of key monitoring drugs, and the relevant departments will manage the key monitoring drugs one round after another A few days ago, at the scene of a meeting, sepiland also learned from the authority in the field of drug regulation that, according to his judgment, the national drug regulation is undergoing a thorough transformation, not centered on industrial development, but on people's health He cautioned that some products with unclear efficacy need to be prepared, and they may face greater regulatory storm ▍ the key monitoring system needs supporting measures The key monitoring catalogue has a great impact on related drugs According to the above industry insiders who do not want to be named, one of his company's varieties has a 50% drop in sales due to being in the catalogue He further said that before the national version of the catalogue was published, there were catalogues of auxiliary drugs (key monitoring) in various provinces, and some of the use of drugs had been stopped In addition, many new drugs are on the market, even if the state does not limit the use of these drugs, their market will be affected However, he also pointed out that the current policies and measures mainly point to pharmaceutical enterprises and corresponding varieties Although the product structure has changed, which has a certain role in cage replacement, some drugs that are temporarily not under key monitoring have risen in sales The establishment direction of the key monitoring system is good, but it is a long-term process to take effect, and the linkage of measures such as breaking the profit seeking mechanism in the hospital is more needed In the end, he also said to saberland, in fact, in the face of the key monitoring drug catalog, the enterprise is relatively passive as a whole Although it pays attention, it can do nothing but let it go In the end, it may have to choose to give up this variety Pharmaceutical enterprises can only focus on the rationality of hospital medication when promoting it as much as possible.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.